Adaptive image-guided radiotherapy in muscle-invasive bladder cancer shows low toxicity and good outcomes

Cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced RCC

Final OS results of IMvigor130: Atezolizumab plus platinum/gemcitabine for mUC

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients

Adjuvant nivolumab as standard of care for high-risk muscle-invasive urothelial carcinoma after radical resection

Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer

JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for advanced urothelial carcinoma

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

Choosing Wisely in haemato oncology and medical oncology

Choosing Wisely in haemato-medical oncology

Choosing Wisely campaigns in Africa

Lessons learned from Choosing Wisely campaigns in Africa